Analogic (ALOG) Rating Lowered to Strong Sell at BidaskClub

Analogic (NASDAQ:ALOG) was downgraded by BidaskClub from a “sell” rating to a “strong sell” rating in a note issued to investors on Saturday.

Other equities analysts also recently issued research reports about the stock. Jefferies Group reissued a “hold” rating and set a $80.00 target price on shares of Analogic in a research note on Friday, December 8th. Zacks Investment Research raised shares of Analogic from a “hold” rating to a “buy” rating and set a $97.00 target price for the company in a research note on Friday, December 8th. One analyst has rated the stock with a sell rating, two have given a hold rating and one has issued a buy rating to the company. The stock has an average rating of “Hold” and a consensus target price of $88.33.

Analogic (NASDAQ ALOG) opened at $84.30 on Friday. Analogic has a 52 week low of $66.00 and a 52 week high of $89.50. The firm has a market cap of $1,052.46, a price-to-earnings ratio of -14.74, a P/E/G ratio of 4.21 and a beta of 0.86.

Analogic (NASDAQ:ALOG) last announced its earnings results on Wednesday, December 6th. The medical research company reported $0.75 earnings per share for the quarter, topping analysts’ consensus estimates of $0.43 by $0.32. Analogic had a negative net margin of 15.06% and a positive return on equity of 5.09%. The business had revenue of $106.90 million during the quarter, compared to the consensus estimate of $100.55 million. During the same quarter last year, the firm earned $0.43 earnings per share. Analogic’s quarterly revenue was down 11.7% on a year-over-year basis. equities analysts anticipate that Analogic will post 2.86 earnings per share for the current fiscal year.

A number of institutional investors and hedge funds have recently bought and sold shares of ALOG. Schwab Charles Investment Management Inc. increased its stake in Analogic by 53.4% in the second quarter. Schwab Charles Investment Management Inc. now owns 111,126 shares of the medical research company’s stock valued at $8,074,000 after purchasing an additional 38,698 shares in the last quarter. First Trust Advisors LP increased its stake in Analogic by 11.0% in the second quarter. First Trust Advisors LP now owns 11,278 shares of the medical research company’s stock valued at $819,000 after purchasing an additional 1,116 shares in the last quarter. Rhumbline Advisers increased its stake in Analogic by 1.4% in the second quarter. Rhumbline Advisers now owns 29,900 shares of the medical research company’s stock valued at $2,172,000 after purchasing an additional 418 shares in the last quarter. SG Americas Securities LLC increased its stake in Analogic by 470.7% in the second quarter. SG Americas Securities LLC now owns 7,619 shares of the medical research company’s stock valued at $554,000 after purchasing an additional 6,284 shares in the last quarter. Finally, Legal & General Group Plc increased its stake in Analogic by 7.7% in the second quarter. Legal & General Group Plc now owns 23,749 shares of the medical research company’s stock valued at $1,725,000 after purchasing an additional 1,696 shares in the last quarter. 97.68% of the stock is owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION NOTICE: “Analogic (ALOG) Rating Lowered to Strong Sell at BidaskClub” was published by Community Financial News and is the property of of Community Financial News. If you are reading this story on another site, it was stolen and republished in violation of United States and international copyright and trademark legislation. The legal version of this story can be viewed at https://www.com-unik.info/2018/01/08/analogic-alog-rating-lowered-to-strong-sell-at-bidaskclub.html.

About Analogic

Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies. The Company operates through three segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography.

What are top analysts saying about Analogic? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Analogic and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit